• ABS (2005) Zevende algemene volks- en woningtelling in Suriname: landelijke resultaten volume I, demografische en sociale karakteristieken. Suriname in Cijfers. (No. 213-2005/02). Algemeen Bureau voor de Statistiek, Paramaribo, Suriname.
  • Adhin MR, Labadie-Bracho M & Vreden SG (2012) Status of potential PfATP6 molecular markers for artemisinin resistance in Suriname. Malaria Journal 11, 322.
  • Bacon DJ, McCollum AM, Griffing SM et al. (2009) Dynamics of malaria drug resistance patterns in the Amazon basin region following changes in Peruvian national treatment policy for uncomplicated malaria. Antimicrobial Agents and Chemotherapy 53, 20422051.
  • Baliraine FN & Rosenthal PJ (2011) Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum Malaria with artemether-lumefantrine in Uganda. The Journal of Infectious Diseases 204, 11201124.
  • Dondorp AM, Nosten F, Yi P et al. (2009) Artemisinin resistance in Plasmodium falciparum malaria. New England Journal of Medicine 361, 455467.
  • Fischer A, Lejczak C, Lambert C et al. (2004) Simple DNA extraction method for dried blood spots and comparison of two PCR assays for diagnosis of vertical human immunodeficiency virus type 1 transmission in Rwanda. Journal of Clinical Microbiology 42, 1620.
  • Gadalla NB, Adam I, Elzaki S-E et al. (2011) Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with artemether-lumefantrine. Antimicrobial Agents and Chemotherapy 55, 54085411.
  • Griffing S, Syphard L, Sridaran S et al. (2010) Pfmdr1 amplification and fixation of pfcrt chloroquine resistance alleles in Plasmodium falciparum in Venezuela. Antimicrobial Agents and Chemotherapy 54, 15721579.
  • Hastings IM & Ward SA (2005) Coartem (artemether-lumefantrine) in Africa: the beginning of the end? The Journal of Infectious Diseases 192, 13031304.
  • Hodel EM, Marfurt J, Müller D et al. (2008) Lack of multiple copies of pfmdr1 gene in Papua New Guinea. Transactions of the Royal Society of Tropical Medicine and Hygiene 102, 11511153.
  • Holmgren G, Hamrin J, Svärd J, Mårtensson A, Gil JP & Björkman A (2007) Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa. Infection, Genetics and Evolution 7, 562569.
  • Humphreys GS, Merinopoulos I, Ahmed J et al. (2007) Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. Antimicrobial Agents and Chemotherapy 51, 991997.
  • Lim P, Alker AP, Khim N et al. (2009) Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Malaria Journal 8, 11.
  • Nkhoma S, Nair S, Mukaka M, Molyneux ME, Ward SA & Anderson TJC (2009) Parasites bearing a single copy of the multi-drug resistance gene (pfmdr-1) with wild-type SNPs predominate amongst Plasmodium falciparum isolates from Malawi. Acta Tropica 111, 7881.
  • PAHO (2010) Report on the Situation of Malaria in the Americas 2008.
  • Phyo AP, Nkhoma S, Stepniewska K et al. (2012) Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. The Lancet 379, 19601966.
  • Plummer WB, Pereira LMP & Carrington CV (2004) Pfcrt and pfmdr1 alleles associated with chloroquine resistance in Plasmodium falciparum from Guyana, South America. Memórias do Instituto Oswaldo Cruz 99, 389392.
  • Price RN, Cassar C, Brockman A et al. (1999) The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrobial Agents and Chemotherapy 43, 2943.
  • Price RN, Uhlemann A-C, Brockman A et al. (2004) Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364, 438447.
  • Price RN, Uhlemann A-C, van Vugt M et al. (2006) Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Clinical Infectious Diseases 42, 15701577.
  • Rogers W, Sem R, Tero T et al. (2009) Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Malaria Journal 8, 10.
  • Takala-Harrison S, Clark TG, Jacob CG et al. (2013) Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia. Proceedings of the National Academy of Sciences USA 110, 240245.
  • WHO (2001) Antimalarial Drug Combination Therapy.
  • WHO (2003) WHO | Position of WHO's Roll Back Malaria Department on Malaria Treatment Policy.
  • Wilson CM, Volkman SK, Thaithong S et al. (1993) Amplification of pfmdr1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Molecular and Biochemical Parasitology 57, 151160.
  • Wongsrichanalai C, Pickard AL, Wernsdorfer WH & Meshnick SR (2002) Epidemiology of drug-resistant malaria. The Lancet Infectious Diseases 2, 209218.
  • Zalis MG, Pang L, Silveira MS, Milhous WK & Wirth DF (1998) Characterization of Plasmodium falciparum isolated from the Amazon region of Brazil: evidence for quinine resistance. The American Journal of Tropical Medicine and Hygiene 58, 630637.